If there's anyone well versed in comparing studies, I'd be curious if similar methods were used vs this study, which says: Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232869/
I realize they are chloroquine vs hydroxychloroquine, but it's curious that hydroxychloroquine was so quickly dismissed (seemingly without evidence at the time) for Sars Cov 2 vs chloroquine being found effective for Sars Cov 1.
rock_accord t1_j3hbruy wrote
Reply to A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii
If there's anyone well versed in comparing studies, I'd be curious if similar methods were used vs this study, which says: Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232869/
I realize they are chloroquine vs hydroxychloroquine, but it's curious that hydroxychloroquine was so quickly dismissed (seemingly without evidence at the time) for Sars Cov 2 vs chloroquine being found effective for Sars Cov 1.